Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 4,975 STVN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | Stevanato Group S.p.A. (STVN) | Grant/Award | 4,975 | n/a |
| Jun 18, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 4,946 | $120.6K |
| Jun 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 5,778 | n/a |
| Nov 25, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 18,052 | $155.8K |
| Jun 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 7,609 | n/a |
| Jun 18, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 10,139 | n/a |
| Jun 2, 2023 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 4,375 | n/a |
| Jun 3, 2022 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 4,312 | n/a |
| Jun 16, 2021 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 25,723 | n/a |